We are live on
!
Find out more
MIM
Meridiem Investment Management Portfolio holdings
AUM
$3.92B
1-Year Est. Return
1.64%
This Fund
S&P 500
This Quarter
Est. Return
+0.83%
1 Year Est. Return
-1.64%
3 Year Est. Return
+34.98%
5 Year Est. Return
+53.7%
10 Year Est. Return
–
AUM
$5.32B
AUM Growth
+$227M
(+4.5%)
Cap. Flow
+$218M
Cap. Flow
% of AUM
4.09%
Top 10 Holdings %
Top 10 Hldgs %
59.5%
Holding
66
New
1
Increased
19
Reduced
15
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$54.1M |
| 2 |
Intuit
INTU
|
+$42.3M |
| 3 |
Align Technology
ALGN
|
+$22M |
| 4 |
Mastercard
MA
|
+$18.5M |
| 5 |
Accenture
ACN
|
+$14.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$27.7M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$9.52M |
| 3 |
Tractor Supply
TSCO
|
+$8.35M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$2.1M |
| 5 |
Apple
AAPL
|
+$336K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 43.52% |
| 2 | Healthcare | 25.58% |
| 3 | Consumer Discretionary | 14.93% |
| 4 | Financials | 11.81% |
| 5 | Communication Services | 4.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Otis Worldwide
OTIS
$27.7B
| $77K | ﹤0.01% |
800
| – | – |
|
52
DexCom
DXCM
$33.1B
| $60.1K | ﹤0.01% |
530
| – | – |
|
53
JPMorgan Chase
JPM
$956B
| $56.6K | ﹤0.01% |
280
| – | – |
|
54
Altria Group
MO
$109B
| $36.4K | ﹤0.01% |
800
-1,500
| -65% | -$66.5K |
|
55
Visa
V
$675B
| $31.5K | ﹤0.01% |
120
-400
| -77% | -$110K |
|
56
Verizon
VZ
$195B
| $28.5K | ﹤0.01% |
690
| – | – |
|
57
Chubb
CB
$134B
| $27.5K | ﹤0.01% |
108
| – | – |
|
58
Wells Fargo
WFC
$265B
| $20.8K | ﹤0.01% |
350
| – | – |
|
59
Immunocore
IMCR
$1.73B
| $19.5K | ﹤0.01% |
575
| – | – |
|
60
Tesla
TSLA
$1.31T
| $11.9K | ﹤0.01% |
60
| – | – |
|
61
Amgen
AMGN
$226B
| – | – |
-800
| Closed | -$227K |
|
62
Brookfield Asset Management
BAM
$84.4B
| – | – |
-1,500
| Closed | -$63K |
|
63
Brookfield
BN
$109B
| – | – |
-9,000
| Closed | -$251K |
|
64
Colgate-Palmolive
CL
$74.3B
| – | – |
-3,000
| Closed | -$270K |
|
65
Procter & Gamble
PG
$340B
| – | – |
-161
| Closed | -$26.1K |
|
66
Philip Morris
PM
$290B
| – | – |
-1,600
| Closed | -$147K |
|
Similar funds
SCM
BCP
AS
MSI
FLSM
TFM
USCWA
DWM
Meridiem Investment Management's Q2 2024 Portfolio in Review
As of Q2 2024, Meridiem Investment Management held 66 positions worth $5.32B, up 4.5% from $5.1B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Meridiem Investment Management deployed $218M of net new capital in Q2 2024, opening 1 new position and adding to 19 existing holdings. Its largest new stake was Blackrock: 885 shares worth $697K.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 43% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Amphenol, an estimated $27.7M trimmed.
- Meridiem Investment Management's largest Q2 2024 buy was Blackrock: 885 shares worth $697K.
- Meridiem Investment Management added most to UnitedHealth in Q2 2024, an estimated $54.1M increase.
- Meridiem Investment Management's biggest Q2 2024 reduction was Amphenol, cutting an estimated $27.7M.
- Meridiem Investment Management fully exited Colgate-Palmolive in Q2 2024, selling an estimated $270K.
- Meridiem Investment Management's ten largest holdings make up 60% of its $5.32B portfolio in Q2 2024.
- Meridiem Investment Management opened 1 new position and closed 6 in Q2 2024.
- Meridiem Investment Management's portfolio value rose 4.5% quarter-over-quarter to $5.32B.
Based on Meridiem Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.